BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26481339)

  • 1. New Reversal Agents for Oral Anticoagulants on the Horizon.
    Mazur MD; Sivakumar W; Taussky P; Park MS
    World Neurosurg; 2015 Dec; 84(6):1506-7. PubMed ID: 26481339
    [No Abstract]   [Full Text] [Related]  

  • 2. Indications and Methods of Anticoagulation Reversal.
    Holzmacher JL; Sarani B
    Surg Clin North Am; 2017 Dec; 97(6):1291-1305. PubMed ID: 29132510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reversal of oral anticoagulation in intracranial hemorrhage].
    Bösel J; Steiner T
    Dtsch Med Wochenschr; 2010 Nov; 135(47):2366-9. PubMed ID: 21082529
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reversal of oral anticoagulation in intracranial hemorrhage].
    Eisfeld S
    Dtsch Med Wochenschr; 2011 Feb; 136(6):280; author reply 280. PubMed ID: 21287434
    [No Abstract]   [Full Text] [Related]  

  • 5. Warfarin reversal.
    Hanley JP
    J Clin Pathol; 2004 Nov; 57(11):1132-9. PubMed ID: 15509671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
    Honickel M; Treutler S; van Ryn J; Tillmann S; Rossaint R; Grottke O
    Thromb Haemost; 2015 Apr; 113(4):728-40. PubMed ID: 25567155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-vitamin K antagonist oral anticoagulant reversal: hope is on the horizon.
    Yorkgitis BK
    Am J Surg; 2016 Jul; 212(1):160-4. PubMed ID: 27182049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH.
    Levy JH; Ageno W; Chan NC; Crowther M; Verhamme P; Weitz JI;
    J Thromb Haemost; 2016 Mar; 14(3):623-7. PubMed ID: 26911798
    [No Abstract]   [Full Text] [Related]  

  • 9. High INR on warfarin.
    Reddy U; Mallepaddi NR; Chevassut TJ
    BMJ; 2015 Apr; 350():h1282. PubMed ID: 25858914
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitamin K and oral anticoagulation: thought for food.
    Bovill EG; Fung M; Cushman M
    Am J Med; 2004 May; 116(10):711-3. PubMed ID: 15121498
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversal agents for NOACs: Connecting the dots.
    Dalal J; Bhave A; Chaudhry G; Rana P
    Indian Heart J; 2016; 68(4):559-63. PubMed ID: 27543482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Travel and oral anticoagulation.
    Ringwald J; Strobel J; Eckstein R
    J Travel Med; 2009; 16(4):276-83. PubMed ID: 19674269
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel oral anticoagulants and diet: the potential for interaction.
    Kamali F
    Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
    [No Abstract]   [Full Text] [Related]  

  • 14. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 15. Are direct oral anticoagulants such as edoxaban safer than heparin or vitamin K-antagonists when intracranial hemorrhage occurs?
    Dempfle CE
    Thromb Res; 2014 Apr; 133(4):521-2. PubMed ID: 24568776
    [No Abstract]   [Full Text] [Related]  

  • 16. On the treatment of new oral anticoagulant-associated gastrointestinal hemorrhage.
    Holster IL; Hunfeld NG; Kuipers EJ; Kruip MJ; Tjwa ET
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):229-31. PubMed ID: 23799225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of overanticoagulation in very elderly hospitalized patients with an INR above 5.0: 24-hour INR response after vitamin K administration.
    Pautas E; Peyron I; Bouhadiba S; Golmard JL; Gouronnec A; Oboa N; Siguret V; Gouin-Thibault I
    Am J Med; 2011 Jun; 124(6):527-33. PubMed ID: 21605730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical implications of new oral anticoagulants: will the potential advantages be achieved?
    Phillips KW; Ansell J
    Thromb Haemost; 2010 Jan; 103(1):34-9. PubMed ID: 20062925
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of vitamin K supplementation on anticoagulant treatment.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    J Thromb Haemost; 2006 Mar; 4(3):691-2. PubMed ID: 16460460
    [No Abstract]   [Full Text] [Related]  

  • 20. The mechanism of action of oral anticoagulants and its consequences for the practice of oral anticoagulation.
    Hemker HC; Frank HL
    Haemostasis; 1985; 15(4):263-70. PubMed ID: 4043827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.